CD4 and breast carcinoma: Despite the lack of statistical significance when considering IL 5 and IL 17 production separately, when we analyzed patients whose CD4+ T-cells produced IL-5 and/or IL-17, we did observe a significant impact on the overall survival (p = 0.01, Fig. 3a) in these elderly breast cancer patients.